MYB rearrangements in Adenoid Cystic Carcinoma: protagonists or secondary characters?

Project Information

SALMYB

Grant agreement ID: 894938

DOI

10.3030/894938

Project closed

EC signature date 3 May 2020

Start date 19 October 2020

End date 18 October 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 212 933,76

EU contribution

€ 212 933,76

Coordinated by

THE UNIVERSITY OF SHEFFIELD
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions

Author(s): Vivian P Wagner, Colin D Bingle, Lynne Bingle
Published in: Critical Reviews in Oncology/Hematology, Issue 18790461, 2022, ISSN 1879-0461
Publisher: Elsevier
DOI: 10.1016/j.critrevonc.2022.103745

Drug-based therapy for advanced adenoid cystic carcinoma: Current landscape and challenges based on an overview of registered clinical trials

Author(s): Vivian Petersen Wagner, Renata Ferrarotto, Pablo Agustin Vargas, Manoela Domingues Martins, Colin D. Bingle, Lynne Bingle
Published in: Critical Reviews in Oncology / Hematology, 2023, ISSN 1040-8428
Publisher: Elsevier BV
DOI: 10.1016/j.critrevonc.2022.103886